2 news items
Aurinia Pharmaceuticals Shareholder Urges Board Of Directors To Take Action To Enhance Shareholder Value; Outlines Concerns Regarding The Company's Current Strategy And Board Composition And Offers Superior Paths To Improving Performance And Market Penetration
AUPH
7 May 24
failed to effectively oversee Mr. Greenleaf and a value-enhancing strategy for Aurinia. Mr. Greenleaf's five-year tenure as CEO has been
Aurinia Pharmaceuticals Shareholder Urges Board of Directors to Take Action to Enhance Shareholder Value
AUPH
7 May 24
. Greenleaf and a value-enhancing strategy for Aurinia. Mr. Greenleaf's five-year tenure as CEO has been marked by repeated drug failures. After
- Prev
- 1
- Next